2252 — Shanghai MicroPort MedBot (Group) Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMid Cap
- HK$21.97bn
- HK$21.69bn
- CNY551.07m
Brief: Shanghai MicroPort MedBot Group Posts H1 Revenue Of RMB99.2 Mln
Brief: Shanghai Microport Medbot Sees Year-On-Year Growth Of 103% To 108% In HY Revenue
Shanghai MicroPort Medical Robot hits record low on discounted share sale
Brief: Shanghai Microport Medbot To Place 12.9 Million New H Shares
Brief: Shanghai Microport Medbot Says Orthobot Suzhou Agreed To Sell Prototypes
Brief: Shanghai Microport Medbot Says Toumai Laparoscopic Surgical Robot Obtained EU CE Mark
Brief: Shanghai Microport Medbot Sees Revenue For Year Will Achieve Year-On-Year Growth Of Over 350%
Brief: Shanghai Microport Medbot Says Surgical Robot Obtained Approval For Marketing by NMPA
Brief: Shanghai Microport Medbot Says Toumai Laparoscopic Surgical Robot Obtained Approval From Nmpa Of China For Multidisciplinary Registration
MicroPort MedBot jumps as China approves launch of hip/knee surgical robot
Brief: Shanghai Microport MedBot Says Skywalker Hip & Knee Arthroplast Surgical Robot Got Launch Approval
Brief: Shanghai Microport Medbot Says HY Loss Attributable RMB539 Million
Brief: Shanghai Microport Medbot Says Skywalker Orthopedic Robot Obtained TGA Certification In Australia
Shanghai MicroPort MedBot at 2-mth peak as DFVision gets safety recognition
Brief: Shanghai Microport Medbot Says Dfvision 3D Electronic Laparoscope Obtained EU CE Mark
Brief: Shanghai Microport Medbot Says Transperineal Prostate Biopsy System Obtained Approval
Brief: Shanghai Microport Medbot Says Skywalker Orthopedic Surgical Robot Obtained Anvisa Certification In Brazil
Brief: Shanghai Microport Medbot Says FY Loss Attributable RMB1.14 Billion
Shanghai MicroPort MedBot hits lowest in over 3-mths on FY loss forecast